Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
deals
life sciences
national blog main
new york blog main
new york top stories
sanofi
3
×
alnylam pharmaceuticals
biotech
boston top stories
clinical trials
fda
national top stories
novartis
san francisco blog main
san francisco top stories
abbvie
akouos
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
biontech
bluerock therapeutics
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
curevac
deerfield management
detroit blog main
What
deal
3
×
medicines
bio
new
acquire
acquisitions
agreed
announced
bets
billion
brings
cancer
cash
ceo
cholesterol
collabs
comes
companies
company
compound
covid
cut
daniel
date
drug
effective
enticed
evidence
fda
gilead
gilead’s
hasn’t
help
introduce
ipo
latest
medco
messenger
molecules
month
Language
unset
Current search:
sanofi
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
